CHICAGO & IRVINE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) and Masimo (Nasdaq: MASI) today announced a joint agreement to integrate Masimo Signal Extraction Technology® (SET®) pulse ...
The Portrait Mobile system’s around-the-clock readings are meant to be an upgrade to traditional in-hospital monitoring methods, which typically check on patients’ vital signs only once every few ...
GE Healthcare and Masimo have announced a joint agreement to integrate Masimo’s Signal Extraction Technology (SET) pulse oximetry into GE’s Portrait Mobile wireless and wearable patient monitoring ...
The newly cleared capability uses AI through the smartSET pulse oximetry sensor platform.
Masimo Corp. ((MASI)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
The FDA clearance allows the W1 wearable to be sold for both over-the-counter and prescription use—making it the first SpO2-tracking smartwatch to carry both indications in the U.S., per Masimo.
NICU Study Adds to the Evidence Demonstrating SET®’s Accuracy in Challenging Real-World Settings, With No Clinically Significant Differences in Performance Across Skin Pigmentation Categories or Race ...
Zacks Investment Research on MSN
Danaher boosts product portfolio with the acquisition of Masimo
Danaher Corporation DHR has completed the acquisition of Masimo Corp. for $180 per share in cash. The transaction was valued at approximately $9.9 billion in total, including assumed debt and net of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results